A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. - Wikidata - awgldk - TriplyDB

A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

http://www.wikidata.org/entity/Q45100252

about

Atrial fibrillation in heart failure: what should we do?European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society Catheter ablation versus rate control for atrial fibrillation: what have we learnt from the ARC-HF trial?2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.Who Needs Catheter Ablation And Which Approach?The current approach of atrial fibrillation management Anticoagulation in Heart Failure: a Review Management Of Atrial Fibrillation In Patients With Heart Failure EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Improvement in quality of life after catheter ablation for paroxysmal versus long-standing persistent atrial fibrillation: a prospective study with 3-year follow-up Atrial fibrillation ablation in systolic dysfunction: clinical and echocardiographic outcomes.Atrial fibrillation ablation and left appendage closure in heart failure patients Efficacy and safety of catheter ablation vs. rate control of atrial fibrillation in systolic left ventricular dysfunction : A meta-analysis and systematic review.Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials.Catheter ablation versus medical rate control for persistent atrial fibrillation in patients with heart failure: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials Efficacy and effects on cardiac function of radiofrequency catheter ablation vs. direct current cardioversion of persistent atrial fibrillation with left ventricular systolic dysfunction.Anticoagulation in Heart Failure: a Review.Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation.Atrial Fibrillation In Heart Failure: New Directions In Diagnosis, Risk Assessment And Risk Reduction.Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.Catheter ablation in patients with persistent atrial fibrillation Catheter Ablation for Persistent and Long-Standing Persistent Atrial Fibrillation Addressing the controversy of rate-versus-rhythm control in atrial fibrillation.Atrial fibrillation in heart failure: catheter and surgical interventional therapies.Arrhythmias in structural heart disease.Atrial fibrillation and heart failure: cause or effect?European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.Comorbidity of atrial fibrillation and heart failure.Catheter ablation of atrial fibrillation in chronic heart failure: state-of-the-art and future perspectives.Avoiding non-responders to cardiac resynchronization therapy: a practical guide.Characterising the difference in electrophysiological substrate and outcomes between heart failure and non-heart failure patients with persistent atrial fibrillation.Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.The burden of proof: The current state of atrial fibrillation prevention and treatment trials.Perioperative Outcomes and Safety of Atrial Fibrillation Catheter Ablation in Octogenarians: A Retrospective Study and Review of the Benefits of Rhythm Control.Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management.Cardiac resynchronization therapy update: evolving indications, expanding benefit?Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study.

P2860

Q26784426-A1E2EB06-F25F-47A8-A97F-A5707627E0A7 Q26796261-1A9E7677-E16D-4D64-8E12-2CBD99A83701 Q27002352-DCB8F5B2-16DF-4628-A27C-1A728BF157A6 Q27341873-ED0EC6EC-CB12-4FC2-8818-191B323CBA29 Q28073160-3547CA12-8DCF-4712-B7DC-2AA69D27C0B5 Q28074710-1FB1AEC3-6D8B-4FEB-B8B6-0B714415D396 Q28076171-C37E902E-50D1-4001-A329-C9481F026B69 Q28087068-04DFE7BD-8083-4018-985E-64E2619AD867 Q30354835-67E7214B-4C3A-4A76-980D-C969887A186F Q30375302-C9C6552B-895D-44F4-87C1-5A87C53220EB Q35026222-ECA155EE-1DF0-45DF-A755-80E33A81CC6B Q35292524-A17A1809-F9B7-4D3D-AE0C-6B8D12517914 Q35755766-491FE74F-7332-4F0B-93AC-2DA68D9C424E Q35849427-0A7D95BA-CFB9-4AB5-A02C-41737676ABBE Q35918565-516996BA-29E8-4B36-8850-2FAF468CD568 Q36089799-7EFBFC16-5C71-40A7-BBEB-5748B0FDA30E Q36325590-900AC788-8555-4887-944B-CEA40D112FCA Q36381170-E6F68DF5-C359-42D0-95D7-291E4240A0F8 Q37364422-018F6473-7244-433F-A7C5-D1D00DCD82C5 Q37469064-586C11A5-3E76-4595-B5E4-CCE14B651E02 Q37678145-862FF175-469C-4D8E-9410-BA5D61AF83C8 Q37704983-2859AAEC-687C-4CF7-94F5-5A4A1C192628 Q37723889-40BE13F6-3CE4-4032-8AA2-67A03AFBFFD5 Q38151445-2D1A2509-C5A0-4E3A-B8DE-16FDC1CD72C6 Q38153249-20E37E66-4588-4833-AF72-7DD882AAA958 Q38221964-18CF08A0-91AA-4A59-B0AA-EF146E77F9C4 Q38254552-27ABE87E-82B9-4F6C-B6D0-280BFE50726E Q38571627-19E8045F-76A0-45B6-8146-694B9B6AD472 Q38654100-85275DEC-75FA-41D7-9E5B-FC9F900C9719 Q38666884-2D33EE0C-EEED-46F6-92AF-74A07C6DA9F5 Q38726564-035C79FA-29F6-4837-8D65-4F82A6F55985 Q38884026-C5B796CC-C9C0-4BDD-8236-50629E6E1CCD Q39008894-99848F94-9C31-4FEA-B92F-0D8A0D018A49 Q39015608-4116FF78-2157-40BF-87B9-2DE492F570B9 Q39119910-7F136916-E809-413C-8406-1B9B5C48D3F1 Q39252564-0BE3CA8B-7321-4CC6-BF7C-76ACA3E7AD43 Q39445718-689FAB2E-2892-4744-8493-64CF24E25E81 Q40616564-D891DEA8-5D8D-43E7-A50A-C453482D5AEB Q40931837-A08DB155-1C0C-49B4-BE48-92CDCA5390F0 Q41019099-D0E7CDFE-AB3C-470C-BAAE-5D3CC19EF0B9

P2860

A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

http://www.wikidata.org/entity/Q45100252

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

A randomized trial to assess c ...... fibrillation in heart failure.

@en

A randomized trial to assess c ...... fibrillation in heart failure.

@nl

type

label

A randomized trial to assess c ...... fibrillation in heart failure.

@en

A randomized trial to assess c ...... fibrillation in heart failure.

@nl

prefLabel

A randomized trial to assess c ...... fibrillation in heart failure.

@en

A randomized trial to assess c ...... fibrillation in heart failure.

@nl

P1433

Q45100252-BB44D25B-71B9-4D25-A111-A6DEE73AFA5E

P1476

Q45100252-24CB3576-9419-44E7-A6EC-52F12644D8F7

P2093

Q45100252-106C9355-9C51-4650-8353-43BC1A6A6688

Q45100252-17ECB592-FD47-495F-B042-1DF151230FA8

Q45100252-30695C0D-7CB7-4D33-8AE5-9C4D6D9AB201

Q45100252-3336D7A9-2099-47B2-97E2-3E1B63B868C9

Q45100252-3F971F0C-AE1D-4527-8E9F-1B66CD362108

Q45100252-59D1D7D5-4848-4258-B97C-EDFEC253621A

Q45100252-7157F044-AB77-4C8E-B500-12D0098222A0

Q45100252-B633E81D-67B5-4F55-8460-019FC038A8D6

Q45100252-CD2193B0-3AA0-4CE7-B15A-DD5DE6843737

Q45100252-E2AF7F7A-C0D6-4A5A-8C48-7A671FA0D072

P304

Q45100252-CFEE9F96-6A59-4990-886F-CBA04086BB86

P31

Q45100252-9155E7F6-E52B-459E-B95A-6B208BB5EC3B

P356

Q45100252-7815C603-F2FF-46C5-AFD4-978C23097A4D

P407

Q45100252-E7DDC859-DDE3-4DEA-9D0F-A1EE0C5C6AB8

P433

Q45100252-0A6DA890-79F2-45A0-84DF-814F35ADDEDD

P478

Q45100252-31D0EFB3-75EE-4410-9CFA-0C22DF1D3C23

P577

Q45100252-BFE306EF-40CE-484F-85CB-9F61A5E991F5

P5875

Q45100252-F0FBD2C2-17BF-456C-9C66-5B9BCAFA41F4

P698

Q45100252-44121F39-D784-4509-BA72-E542B28B1A0E

P921

Q45100252-0FCF3554-1DA8-4476-8A37-6C5A45F9D164

Q45100252-7876BF26-14E1-4FE1-8EAB-FF9A5DDFC04C

Q45100252-C673BC9D-D458-4579-93B5-722492B51CCF

P356

J.JACC.2013.01.069

P1433

Journal of the American College of Cardiology

P1476

A randomized trial to assess c ...... fibrillation in heart failure.

@en

P2093

Darrel P Francis

http://www.w3.org/2001/XMLSchema#string

David G Jones

http://www.w3.org/2001/XMLSchema#string

Rakesh Sharma

http://www.w3.org/2001/XMLSchema#string

S Richard Underwood

http://www.w3.org/2001/XMLSchema#string

Shelley L Rahman-Haley

http://www.w3.org/2001/XMLSchema#string

Shouvik K Haldar

http://www.w3.org/2001/XMLSchema#string

Theresa A McDonagh

http://www.w3.org/2001/XMLSchema#string

Tom Wong

http://www.w3.org/2001/XMLSchema#string

Vias Markides

http://www.w3.org/2001/XMLSchema#string

Wajid Hussain

http://www.w3.org/2001/XMLSchema#string

P304

1894-1903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2013.01.069

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236054668

http://www.w3.org/2001/XMLSchema#string

P698

23500267

http://www.w3.org/2001/XMLSchema#string

P921

catheter ablation

atrial fibrillation